Portal de Periódicos da CAPES

Private Equity's Game Plan and Why it Should Matter to Us

2020; Volume: 51; Issue: 8 Linguagem: Inglês

10.3928/23258160-20200804-01

2325-8179

Veeral Sheth, Dilsher S. Dhoot, Seenu M. Hariprasad,

Financial Literacy, Pension, Retirement Analysis

Practical RetinaPrivate Equity's Game Plan and Why it Should Matter to Us Veeral Sheth, MD, MBA, , , MD, MBA Dilsher Dhoot, MD, , and , MD Seenu M. Hariprasad, Veeral Sheth, MD, MBA , Dilsher Dhoot, MD , and Seenu M. Hariprasad Published Online:August 04, 2020https://doi.org/10.3928/23258160-20200804-01PDFView Full Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1.Shattering of Industry, Global Silos Drives Healthcare Deal Activity. Pitchbook. https://pitchbook.com/newsletter/shattering-of-industry-silos-drives-us-healthcare-life-sciences-deal-activity. Published April 12, 2019. Accessed November 26, 2019. Google Scholar2.PE Investment in Physician Practice Management ‒ What's to Come in 2019?BakerHostetler. https://www.bakerlaw.com/alerts/pe-investment-in-physician-practice-management-whats-to-come-in-2019. Published February 13, 2019. Accessed November 23, 2019. Google Scholar3.Konda S, Francis J, Motaparthi K, Grant-Kels JMGroup for Research of Corporatization and Private Equity in Dermatology. Future considerations for clinical dermatology in the setting of 21st century American policy reform: corporatization and the rise of private equity in dermatology. J Am Acad Dermatol. 2019; 81(1):287–296.e8. 10.1016/j.jaad.2018.09.052 PMID:30296541 Crossref Medline, Google Scholar4.MacArthur H. Bain & Company's Global Private Equity Report 2018. Bain & Company. https://www.bain.com/insights/global-private-equity-report-2018. Published February 26, 2018. Accessed November 24, 2019. Google Scholar5.MacArthur H. Bain and Company. Global Private Equity Report2017. https://www.bain.com/insights/global-private-equity-report-2017. Published February 27, 2017. Accessed November 23, 2019. Google Scholar6.Patel SN, Groth S, Sternberg P. The emergence of private equity in ophthalmology. JAMA Ophthalmol. 2019; 137(6):601–602. 10.1001/jamaophthalmol.2019.0964 PMID:31046063 Crossref Medline, Google Scholar7.United States Files False Claims Act Complaint Against Compounding Pharmacy, Private Equity Firm, and Two Pharmacy Executives Alleging Payment of Kickbacks. United States Department of Justice. The United States Attorney's Office, Southern District of Florida. https://www.justice.gov/usao-sdfl/pr/united-states-files-false-claims-act-complaint-against-compounding-pharmacy-private. Published February 23, 2018. Accessed November 24, 2019. Google Scholar8.Family Dermatology PcC Agrees to Pay United States More Than $3.2 Million to Settle Alleged False Claims Act Violations. The United States Department of Justice, Office of Public Affairs. https://www.justice.gov/opa/pr/family-dermatology-pcc-agrees-pay-united-states-more-32-million-settle-alleged-false-claims. Published April 21, 2015. Accessed November 24, 2019. Google Scholar9.Hafner K, Palmer G. Skin Cancers Rise, Along With Questionable Treatments. https://www.nytimes.com/2017/11/20/health/dermatology-skin-cancer.html. Published November 20, 2017. Accessed November 24, 2019. Google Scholar10.Court EAmerican Medical Association to investigate whether private-equity-owned practices put profits over patients. MarketWatch. https://www.marketwatch.com/story/responding-to-doctors-concerns-american-medical-association-will-investigate-role-of-private-equity-and-other-companies-2018-06-18. Published June 18, 2018. Accessed November 24, 2019. Google Scholar11.Private Equity Spotlight – May 2016. Preqin. https://www.preqin.com/insights/spotlight-newsletters/private-equity-spotlight-may-2016/14428. Published May 13, 2016. Accessed November 24, 2019. Google Scholar12.Baker-Schena L. Private Equity and Ophthalmology. Eyenet Magazine. 2019;(Nov):39–44. Google Scholar13.Sharfstein JM, Slocum J. Private Equity and Dermatology – First, Do No Harm. JAMA Dermatol. 2019July24. 10.1001/jamadermatol.2019.1322. Online ahead of print. PMID:31339511 Crossref Medline, Google Scholar Previous article Next article FiguresReferencesRelatedDetails Request Permissions InformationCopyright 2020, SLACK IncorporatedPDF downloadVeeral Sheth, MD, MBA, can be reached at 15947 W 127th St., Suite E, Lemont, IL 60439; email: [email protected]com.Seenu M. Hariprasad, MD, can be reached at University of Chicago, Department of Ophthalmology and Visual Science, 5841 S. Maryland Ave., Room S-439, Chicago, IL 60637; email: [email protected]edu.Dilsher S. Dhoot, MD, can be reached at California Retina Consultants, 525 E. Micheltorena Street, Suite A, Santa Barbara, CA 93103; email: [email protected]com.Disclosures: Drs. Sheth and Dhoot report no relevant financial disclosures.Dr. Hariprasad is a consultant or on the speakers bureau for Allergan, Novartis, Biogen, Graybug, EyePoint, Alimera Sciences, Spark, and Regeneron.